EGFR and breast cancer: In contrast, AKT1 (HR = 096, log-rank P = 0.87), EGFR (HR = 1.1, log-rank P = 0.66), CASP3 (HR = 1.04, log-rank P = 0.68), SRC (HR = 0.97, log-rank P = 0.31), MDM2 (HR = 1.05, log-rank P = 0.15), MAPK1 (HR = 1.31, log-rank P = 0.05) and RHOA (HR = 1.37, log-rank P = 0.76) were not significantly associated with OS in BC patients.